Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf your Mounjaro pen appears stuck on the last dose indicator, you have almost certainly used all four doses in the pen. Each KwikPen is pre-filled with four weekly doses, and once the final dose is delivered the pen locks automatically as a built-in safety feature. That locked position is not a fault. It means the pen has done its job. Your next step is to dispose of it safely and move on to a new pen for the following week's injection — not to force or retry the one in your hand. As with all stages of your treatment, any genuine uncertainty about what you experienced should be discussed with your prescribing team, because Mounjaro is a prescription-only medicine and dose decisions rest with your clinician.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Mounjaro KwikPen is engineered so that it cannot be pressed beyond the fourth and final dose. When you reach that point, the plunger reaches its physical stop and the pen body locks. You will notice the dose indicator is at or near zero, and the button will not depress further. This is deliberate. The lock prevents anyone from attempting to extract residual medication, the tiny amount that remains after dose four is dead volume in the design, not a usable fifth injection.
Some people find the final-dose position looks different from earlier doses and worry the pen jammed mid-injection rather than completing. A quick way to check: hold the pen window up to the light and look at the dose counter. If it reads zero or shows the last marker, the dose was delivered. If the counter still shows a partial number, or if you felt unusual resistance mid-press and the button stopped before you expected, that is worth querying with your prescriber before assuming the dose went in fully.
The NHS patient information page for tirzepatide advises that if you think you have missed a dose or are uncertain whether a dose was given, you should follow the guidance in the Patient Information Leaflet supplied with the pen. Our guide on a pen that jammed at the last dose covers the distinction between a genuine device fault and a completed lock in more detail.
No. Once a Mounjaro KwikPen has locked, attempting to force additional injections carries real risks. The needle-retraction mechanism will have completed its cycle, so pressing again does not simply release medication, it risks the needle extending unexpectedly, causing a needlestick injury to your hand or finger. Beyond the injury risk, a fully delivered pen contains no further therapeutic dose. You would be pressing on an empty chamber.
A separate scenario: if the pen felt as though it locked early (before you were confident the injection was complete) do not attempt a second press immediately. Recap the pen with care, note the time, and contact your prescribing team. They will advise whether a replacement dose is appropriate. Eli Lilly's patient support line can also help with device queries specific to the KwikPen mechanism.
For questions about what to expect with an earlier dose during the same pen cycle, our overview of the pen stuck on the 4th dose addresses that point directly. If you want to understand the broader question of whether using that final dose position is ever ambiguous, the guide on using the last dose of Mounjaro runs through the practical detail.
Dispose of it safely, straight away. The correct container is a sharps bin, a rigid, puncture-resistant yellow sharps container, not a household bin or a glass jar. Many UK councils collect sharps bins from your home; your GP surgery or pharmacy can also advise on the nearest drop-off point. Never place a used pen in the general recycling: the retracted needle can still cause injury.
After disposal, note the date so you know when your next dose is due. Mounjaro is a once-weekly injection, and the schedule continues from the same day of the week regardless of whether the previous pen felt smooth or slightly resistant. If you are mid-titration (moving from 2.5mg up through the schedule) your next pen will be at whatever strength your prescriber has confirmed. That detail is worth reviewing in our resource on the Mounjaro last dose, which explains the handover from one pen to the next.
Keeping a dedicated sharps container beside wherever you store your pens makes this habit genuinely effortless, open the lid, drop the pen in, done. It takes five seconds and removes the risk of a loose pen in the medicine cabinet.
Most of the time, a pen stuck on the last dose is simply a pen that has finished. But there are three situations worth raising with your prescribing team rather than moving on quietly. First, if you felt the injection stop unusually early and the pen locked before the normal slow ten-second hold was complete. Second, if you noticed blood or fluid at the injection site in a pattern that suggested the needle had not stayed seated. Third, if you are comparing your experience to a previous pen and something felt genuinely different.
Your prescriber can advise whether a replacement dose is clinically appropriate and update your treatment notes accordingly. If you are a patient at a GPhC-registered pharmacy like ours, your prescribing team reviews your case before every repeat order, it is exactly the kind of query they expect to field. The full Mounjaro overview also explains how the titration schedule works and what your prescriber is looking for at each stage.
For context on the broader treatment journey, including cost across different doses as you move up the schedule, the Mounjaro price guide sets out what private treatment typically involves at each pen strength. And if you have questions that are not device-related (about eating, drinking, or other aspects of life on tirzepatide) our FAQs cover the questions our prescribers hear most often. When you're ready to discuss your options with a clinician, check your eligibility and start a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.